AEV
0.009
50%
KFM
0.061
-21.8%
VTA
0.021
31.3%
CMO
0.004
-20%
HIQ
0.005
25%
SRJ
0.004
-20%
VKA
0.011
22.2%
DTZ
0.026
-18.8%
WCN
0.023
21.1%
TZN
0.019
-17.4%
A8G
0.21
20%
FAU
0.01
-16.7%
MGU
0.006
20%
PL9
0.005
-16.7%
ABE
0.037
19.4%
UNT
0.005
-16.7%
JAV
0.097
18.3%
BRY
0.011
-15.4%
HMD
0.039
18.2%
CMP
0.235
-14.5%
SLA
0.13
18.2%
AGN
0.15
-14.3%
NYM
0.053
17.8%
GEN
0.006
-14.3%
EAU
0.14
16.7%
LRM
0.018
-14.3%
INF
0.007
16.7%
M4M
0.006
-14.3%
XST
0.014
16.7%
X2M
0.006
-14.3%
KLI
0.325
16.1%
SLB
0.275
-14.1%
HVY
0.4
15.9%
NOX
0.065
-13.3%
REC
0.037
15.6%
AS2
0.007
-12.5%
AHE
0.015
15.4%
AUV
0.007
-12.5%
KOB
0.032
14.3%
MRD
0.042
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Pilbara Minerals (ASX:PLS): Extends off take agreement

Australian lithium producer Pilbara Minerals Limited (ASX:PLS) announces it has executed an amendment to its existing offtake agreement with Chengxin Lithium which materially extends & expands the supply of spodumene concentrate to a leading lithium chemical converter. Read the ASX announcement here: https://lnkd.in/gbq9pNuP

Augustus Minerals (ASX:AUG): Exploring for lithium, rare earths & copper

Critical minerals explorer Augustus Minerals (ASX:AUG) owns a wide expanse of tenements located within the Western Australia-based Gascoyne Province (both in the Shire of Upper Gascoyne and the Shire of Carnarvon). These assets contain an array of high-quality drill targets, which are highly prospective for lithium, rare earths and copper. The company’s recent drill activities […]

TruScreen (ASX:TRU): Approval

TruScreen (ASX:TRU) says the national regulator of Mexico, Cofepris, has approved TruScreen access to the public health sector, allowing TruScreen to expand its cervical cancer screening | ASX announcement: https://announcements.asx.com.au/asxpdf/20240207/pdf/06053x7zdwhmgv.pdf

BetMakers (ASX:BET): Partnership

BetMakers (ASX:BET) announces a new 5-year partnership, with PA Betting Services, to launch a broadcast streaming and wagering platform for intended distribution into world racing markets | ASX announcement: https://announcements.asx.com.au/asxpdf/20240206/pdf/0603srw9p3kdx1.pdf

Hazer Group (ASX:HZR): Successful transformation

Leading clean-technology developer Hazer Group (ASX:HZR), successfully transformed methane and iron-ore into hydrogen and graphite at its commercial demonstration plant | https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02768165-6A1192220 #Hydrogen #Graphite #ESG

4DS Memory (ASX:4DS): Achieved new milestone

4DS Memory (ASX:4DS) says it has achieved a new write speed milestone which it says clearly establishes 4DS as the industry leader in potentially bringing Interface Switching ReRAM to market | ASX announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02769137-6A1192641

Capstone Copper Corp (ASX:CSC) lists on the ASX

Capstone Copper Corp (ASX:CSC) has a portfolio of long-life copper operations in the Americas and a fully permitted development project in one of the world’s most prolific copper-producing districts | Website: https://capstonecopper.com/ #stocks #ASXIPO

Althea Group Holdings (ASX:AGH): Signed contract

Althea Group Holdings’ (ASX:AGH) wholly-owned subsidiary, Peak Processing Solutions has signed a Contract Manufacturing Agreement with Collective Project, a leading cannabis-infused beverage brand in Canada | ASX announcement: https://announcements.asx.com.au/asxpdf/20240202/pdf/0600lvtbvffvjc.pdf #$AGH

Singular Health Group (ASX:SHG): Expansion

Medical technology company Singular Health Group (ASX:SHG) has scored its first enterprise sale in the US medical education market, winning a binding purchase order for 3Dicom licenses for Roseman University of Health Sciences in Las Vegas, Nevada | ASX announcement: https://announcements.asx.com.au/asxpdf/20240201/pdf/05zzjvjrzkktr7.pdf

Cyclopharm (ASX:CYC): Partnership

Global radiopharmaceutical company Cyclopharm (ASX:CYC) has entered into a standard commercial partnership with Yale following Technegas’ approval by the U.S. FDA | https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02766065-2A1501471